Delivery Order SPE2DB20D3103-SPE2DB24FN6G4
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $4.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,640.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $4,442.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Lidocaine 5% Patches. It is a firm-fixed-price contract with a completion date of January 12, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,644.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of May 10, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $13,111.70, is a Delivery Order for the provision of Lidocaine 5% Patches. The award has a completion date of May 3, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine 5% Patch 30S. The contract, valued at $12,422.33, has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- This federal contract award, valued at $13,429.67, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,313.55, is for the delivery of Lidocaine 5% patches to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2022. There was no set-aside designation for this award, indicating it was open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,694.10, is for the delivery of Lidocaine 5% Patches. This is a firm fixed-price delivery order contract with a completion date of February 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,836.47, is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has a completion date of December 4, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide...
- This federal contract award, valued at $5,843.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...